Our shop is now LIVE!

About Us

Meet riley's Team

Throughout Riley’s battle, she inspired others to work together. The Riley Rocks Memorial Foundation team members have come together to draw awareness and offer support for families and children who are affected by pediatric cancer.

Kamie Fessenden

Riley's Mom

Co-Founder

Riley's Dad

Todd Fessenden

Co-Founder

Kendel Davy

Family Outreach Representative

Meghan Fessenden

Riley's Sister

Director of social media marketing

Amy Nesbit

Development coordinator

Cameron Jones

Community outreach coordinator

help make a difference

There are plenty of ways you can help contribute to The Riley Rocks Foundation.
Our Inspiration

Riley's Story

“We raise funds so that kids don’t have to spend summers inside a hospital. So that little girls don’t have to worry about covering up their bald head. So the next little girl who just wants to grow up to be a preschool teacher, can.”

- Riley's Team

Riley Bridget Fessenden was born in Beverly, Massachusetts on April 9, 2007. She is the daughter of Todd and Kamie Fessenden and sister to Drew, Meghan, and Daniel Fessenden. Riley wanted to be a preschool teacher when she grew up. She was the most positive little girl and she always had a smile on her face.

Shortly after Riley’s 6th birthday she was diagnosed with stage four Esthesioneuroblastoma, a rare form of cancer affecting the nasal and brain cavities. When Riley was diagnosed the doctors told her parents she had three months to live. After 3 years, 104 radiation treatments, 14 rounds of chemotherapy, too many hospital stays, medications, and blood transfusions Riley was still fighting with courage and bravery that no child should have to express.

Riley was a cheerleader, softball player, and Irish step dancer. She often went straight from radiation to cheer practice. She spent birthdays, holidays, and multiple fundraisers donating toys, giftcards, and money to the hospitals and organizations that were a part of Riley’s battle. She told her story and did whatever it might take to make others smile.

The summer after Riley turned nine years old she passed away. The impact she made on others is truly remarkable. Days were named after her and parks were created in her memory. Tens of thousands of dollars continue to be raised for cancer research in her honor. Riley became a hero to so many. Riley may have lost her battle but she has taught us that there is always HOPE.

We support families fighting those same battles. Riley is just one story. One of way too many. We raise funds so that kids don’t have to spend summers inside a hospital. So that little girls don’t have to worry about covering up their bald head. So the next little girl who just wants to grow up to be a preschool teacher, can.

Understanding Childhood Cancer

Childhood cancer does not discriminate. It affects every ethnic group and socioeconomic class in every geographic region around the world.

  • Childhood cancer is the leading cause of death by disease in children under the age of 19 in the U.S.
  • One in 285 children in the U.S. will be diagnosed with cancer by the time they are 20 years old.
  • Every day in the U.S. 43 children between the ages of 0-19 are diagnosed with childhood cancer.
    • 20% of those children will not survive.
  • Survivors are twice as likely to suffer chronic health conditions.
  • At any given time more than 40,000 children are on active treatment in the U.S.
  • Childhood cancer is not one disease. There are hundreds of types of pediatric cancer.

You can help change these statistics! Know the facts, share the facts and share the stories of children behind these facts. By raising funding and awareness, researchers can move closer to understanding childhood cancers, treating childhood cancers and ultimately curing childhood cancers.

15,000

Children are diagnosed with pediatric cancer every year in the U.S.

3

children under the age of 15 will die from cancer every day in the U.S.

4%

of the annual NIH budget for cancer research is dedicated to childhood cancer.

4

drugs have been approved by the FDA for childhood cancer in the last 20 years.